04D-600-D256-1

MERIDIA News

Media Mentions

MERIDIA has been discussed in many of today’s leading publications.

Please note: The links below will take you outside MERIDIA.net to another website, which will open in a new browser window. To return here, just close that new browser window.

  • 08/17/05

    ABBOTT STATEMENT REGARDING U.S. FOOD AND DRUG ADMINISTRATION'S DENIAL OF PUBLIC CITIZEN'S PETITION AGAINST MERIDIA® (SIBUTRAMINE HCL MONOHYDRATE) CAPSULES C-IV

    Read the Abbott Press Release. Or, see the full FDA Statement

    • 04D-600-D256-25

  • 07/14/04

    U.S. DISTRICT COURT DISMISSES CLAIMS AGAINST ABBOTT LABORATORIES' ANTI-OBESITY MEDICATION MERIDIA ®

    Download PDF

Up to Top

07B-600-T727-3 | 07B-600-T727-4


Home | Contact Us | Use and Safety Information | U.S. Prescribing Information
Privacy Policy | Terms of Use

Copyright © 2006, 2007 Abbott Laboratories. Abbott Park, Illinois, U.S.A.

The health information contained herein is provided for informational purposes only and is not intended to replace a discussion with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider and consider the unique characteristics of each patient.

The information contained in MERIDIA.net is intended for use only by United States residents. Countries outside of the United States may have regulatory requirements, data measurements, or medical practices that may differ from those in the United States. Therefore, this information may not be appropriate for use outside the United States.

If you have any questions about MERIDIA that have not been answered on this site click to contact us or call Abbott Medical Information at 1-800-633-9110.

04D-600-D256-4